Mary Beth Bennett
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Mary Beth Bennett
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Inspire Pharmaceuticals, Inc.
 Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ.
17
| Extinct | Pharmaceuticals: Major | 17 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mary Beth Bennett tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
Applied Immune Sciences, Inc.
 Applied Immune Sciences, Inc. Medical SpecialtiesHealth Technology Part of Sanofi, Applied Immune Sciences, Inc. is a surgical and medical instruments company. The company is based in Menlo Park, CA. The company was founded by Thomas B. Okarma. Applied Immune Sciences was acquired by Rhone-Poulenc Rorer, Inc. on November 28, 1995 for $84.40 million. | Medical Specialties | Corporate Officer/Principal | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member Chairman | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Founder | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AFFYMETRIX, INC. | Medical Specialties | Corporate Officer/Principal | |
Heartport, Inc.
 Heartport, Inc. Medical SpecialtiesHealth Technology Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA. | Medical Specialties | Corporate Officer/Principal | |
| NUO THERAPEUTICS, INC. | Medical Specialties | Director/Board Member | |
Serenex, Inc.
 Serenex, Inc. Pharmaceuticals: MajorHealth Technology Serenex, Inc. operates as a biotechnology company that develops drugs for tumors and cancers of the blood and bone marrow. Its products include drugs for chemotherapy treatments as well as inhibitor compounds. Serenex was founded by George Young and Timothy Haystead in 2000 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chief Executive Officer | |
Cempra Pharmaceuticals, Inc.
 Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | Biotechnology | Director/Board Member | |
CSA Medical, Inc.
 CSA Medical, Inc. Medical SpecialtiesHealth Technology CSA Medical, Inc. develops endoscopic cryoablation systems. It provides spray cryotherapy medical device solutions that improve patient outcomes, simplify procedures, and reduce the cost of healthcare. The company was founded by Lloyd Shue, Timothy E. Askew and Frank Majerowicz in 1985 and is headquartered in Lexington, MA. | Medical Specialties | Director/Board Member | |
Esanex, Inc.
 Esanex, Inc. Pharmaceuticals: MajorHealth Technology Esanex, Inc. manufactures and develops drugs for cancer treatment. Its products include orally active Hsp90 inhibitors. The company was founded in 2011 and is headquartered in Indianapolis, IN. | Pharmaceuticals: Major | Director/Board Member | |
Aerami Therapeutics Holdings, Inc.
 Aerami Therapeutics Holdings, Inc. Medical SpecialtiesHealth Technology Dance Biopharm Holdings, Inc. engages in providing health care services. The company was founded by John Stuart Patton in 2010 and is headquartered in San Francisco, CA. | Medical Specialties | Director/Board Member | |
Innocrin Pharmaceuticals Holdings LLC
 Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC. | Medical Specialties | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Circadian, Inc.
 Circadian, Inc. Medical SpecialtiesHealth Technology Circadian, Inc. manufactures electro-medical equipment. The company was founded by Martin Moore-Ede in 1983 and is headquartered in Stoneham, MA. | Medical Specialties | Corporate Officer/Principal | |
| AFFYMAX, INC. | Biotechnology | Corporate Officer/Principal | |
Ardent Pharmaceuticals, Inc.
 Ardent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ardent Pharmaceuticals, Inc. researches and develops drugs for pain, urinary incontinence, premature ejaculation, depression and cardio protection. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
| James Madison University | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| University of California San Diego | College/University | Doctorate Degree | |
| University of Kentucky | College/University | Doctorate Degree Graduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Masters Business Admin | |
Covelight Systems, Inc.
 Covelight Systems, Inc. Information Technology ServicesTechnology Services Covelight Systems, Inc. provides marketing application security and fraud detection solutions. Its patent-pending solutions deliver actionable intelligence in the form of real-time incident detection and notification. The company was founded by David Logan in 2003 and is headquartered in Cary, NC. | Information Technology Services | Director/Board Member | |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Internet Software/Services | Director/Board Member | |
Hatteras Venture Partners
 Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Investment Managers | Private Equity Investor Consultant / Advisor | |
CEO Roundtable on Cancer, Inc.
 CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services CEO Roundtable on Cancer, Inc. promotes activities to reduce cancer risk, enable early detection, facilitate better access to treatment and hasten the discovery. Its programs include CEO cancer gold standard, life sciences consortium and project data sphere. The company was founded by George H. W. Bush in 2001 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chief Executive Officer | |
Council for Entrepreneurial Development
 Council for Entrepreneurial Development Miscellaneous Commercial ServicesCommercial Services Council for Entrepreneurial Development provides an interactive forum for entrepreneurs, investors, service professionals, academicians, researchers and public policy makers. Its services and programs include connections to capital, venture mentoring, and signature conferences empower member companies to go further. The company was founded in 1984 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
NC Life Sciences Organization
 NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services North Carolina Biosciences Organization is non-profit organization, which focuses on legislative monitoring and lobbying activities at the state and federal level. The company was founded in 1994 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Triangle Community Foundation | Financial Conglomerates | Director/Board Member Director/Board Member | |
| The University of North Carolina at Charlotte | College/University | Graduate Degree Graduate Degree | |
Vascular Pharmaceuticals, Inc.
 Vascular Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vascular Pharmaceuticals, Inc. develops and commercializes therapeutics for the treatment of diabetics. It provides new treatment options to individuals living with diabetic complications such as nephropathy. The company was founded by David R. Clemmons and Laura Maile in 2005 and is headquartered in Research Triangle Park, NC. | Pharmaceuticals: Major | Director/Board Member | |
Aerami Therapeutics, Inc.
 Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member | |
| EYENOVIA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| OLD API WIND-DOWN LTD. | Pharmaceuticals: Major | Director/Board Member | |
| A M Pappas & Associates LLC | President | ||
Project Data Sphere LLC
 Project Data Sphere LLC Data Processing ServicesTechnology Services Project Data Sphere LLC is a private company that focuses on breaking down barriers to cancer clinical trial data sharing. The company is based in Morrisville, NC. The company believes that valuable trial data should ultimately benefit the patients who participate in them. The company aggregates trial data from biopharmaceutical companies, academic medical centers, and government organizations and makes it freely available. The CEO of the company is Kenneth B. Lee. | Data Processing Services | Chief Executive Officer | |
Innocrin Pharmaceuticals, Inc.
 Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 48 |
| Regno Unito | 3 |
| Canada | 2 |
Settori
| Health Technology | 32 |
| Consumer Services | 8 |
| Technology Services | 4 |
| Finance | 4 |
| Commercial Services | 4 |
Posizioni
| Director/Board Member | 89 |
| Corporate Officer/Principal | 48 |
| Independent Dir/Board Member | 27 |
| Chairman | 18 |
| Undergraduate Degree | 15 |
Contatti più connessi
| Insiders | |
|---|---|
| Kenneth Lee | 40 |
| William Ringo | 32 |
| Nancy Hutson | 19 |
| Kip A. Frey | 19 |
| Rick S. Kent | 18 |
| Wilmer Leigh Thompson | 12 |
| Joseph Schachle | 11 |
| Alan Holmer | 11 |
| Gregory J. Mossinghoff | 8 |
| Thomas Staab | 8 |
| Bart J. Dunn | 8 |
| Romulus Brazzell | 8 |
| Gerald W. St. Peter | 7 |
| Raymond W. Hines | 6 |
| Joseph M. Spagnardi | 4 |
- Borsa valori
- Insiders
- Mary Beth Bennett
- Connessioni Società
